Hanaguri, J.; Nagai, N.; Yokota, H.; Kushiyama, A.; Watanabe, M.; Yamagami, S.; Nagaoka, T.
Fenofibrate Nano-Eyedrops Ameliorate Retinal Blood Flow Dysregulation and Neurovascular Coupling in Type 2 Diabetic Mice. Pharmaceutics 2022, 14, 384.
https://doi.org/10.3390/pharmaceutics14020384
AMA Style
Hanaguri J, Nagai N, Yokota H, Kushiyama A, Watanabe M, Yamagami S, Nagaoka T.
Fenofibrate Nano-Eyedrops Ameliorate Retinal Blood Flow Dysregulation and Neurovascular Coupling in Type 2 Diabetic Mice. Pharmaceutics. 2022; 14(2):384.
https://doi.org/10.3390/pharmaceutics14020384
Chicago/Turabian Style
Hanaguri, Junya, Noriaki Nagai, Harumasa Yokota, Akifumi Kushiyama, Masahisa Watanabe, Satoru Yamagami, and Taiji Nagaoka.
2022. "Fenofibrate Nano-Eyedrops Ameliorate Retinal Blood Flow Dysregulation and Neurovascular Coupling in Type 2 Diabetic Mice" Pharmaceutics 14, no. 2: 384.
https://doi.org/10.3390/pharmaceutics14020384
APA Style
Hanaguri, J., Nagai, N., Yokota, H., Kushiyama, A., Watanabe, M., Yamagami, S., & Nagaoka, T.
(2022). Fenofibrate Nano-Eyedrops Ameliorate Retinal Blood Flow Dysregulation and Neurovascular Coupling in Type 2 Diabetic Mice. Pharmaceutics, 14(2), 384.
https://doi.org/10.3390/pharmaceutics14020384